Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI

NuklearMedizin

Volumn 38, Issue 8, 1999, Pages 312-318

  Nowak, Bernd ^a   Di Martino, E ^b   Janicke S ^b   Cremerius, U ^b   Adam, G ^b   Zimny, M ^b   Reinartz, P ^b   Bull U ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NONE

Author keywords

Computerized tomography; F 18 FDG PET; Grading; Head and neck cancer; Magnetic resonance imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY;

EID: 0032763898     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632228     Document Type: Article

References (43)

1. AAssar OS, Fischbein NJ, Caputo GR et al. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology 1999; 210: 177-81.
2. Adams S, Baum RP, Stuckensen T et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998; 25: 1255-60.
3. Anzai Y, Carroll WR, Quint DJ et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996; 200: 135-41.
4. Bailet JW, Ahemayor E, Jabour BA et al. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992; 102: 281-8.
5. Bailet JW, Sercarz JA, Abemayor E et al. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope 1995; 105: 135-9.
6. Benchaou M, Lehmann W, Slosman DO et al. The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol (Stockh) 1996; 116: 332-5.
7. Braams JW, Pruim J, Freling NJM et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995; 36: 211-6.
8. Braams JW, Pruim J, Kole AC et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg 1997; 26: 112-5.
9. Cremerius U, Striepecke E, Henn W et al. 18FDG-PET in intracranial meningiomas versus grading, proliferation index, cellular density and cytogenetical analysis. Nuklearmedizin 1994; 33: 144-9.
10. Di Chiro G. Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1986; 22: 360-71.
11. Eichhorn T, Schroeder HG, Glanz H, Schwerk WB. Histologically controlled comparison of palpation and sonography in the diagnosis of cervical lymph node metastases. Laryngol Rhinol Otol 1987; 66: 266-74.
12. Feinmesscr R, Freeman JL, Feinmesser M et al. Role of modern imaging in decision- making for elective neck dissection. Head Neck 1992; 14: 173-6.
13. Fischbein NJ, AAssar OS, Caputo GR et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Am J Neuroradiol 1998; 19: 1189-96.
14. Glazer H, Niemeyer JH, Blafer DM. Neck neoplasms: MRI imaging part I. Initial evaluation. Radiology 1986; 160: 343-8.
15. Greven KM, Williams III DW, Keyes JW Jr et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994; 74: 1355-9.
16. Greven KM, Williams DW 3rd, Keyes JW Jr et al. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Cancer J Sci Am 1997; 3: 353-7.
17. Griffeth LK, Dehdashti F, McGuire AH et al. PET evaluation of soft tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 1992; 182: 185-94.
18. Haberkorn U, Strauss LG, Reisser Ch et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 1991; 32: 1548-55.
19. Jabour BA, Choi Y, Hoh CK et al. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993; 186: 27-35.
20. Kole AC, Nieweg OE, Pruim J et al. Detection of unknown occult primary tumors using positron emission tomography. Cancer 1998; 82: 1160-6.
21. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics. 1999. Ca Cancer J Clin 1999; 49: 8-31.
22. Lapela M, Grenman R, Kurki T et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995; 197: 205-11.
23. Laubenbacher C, Saumweber D, Wagner-Manslau C et al. Comparison of fluorine-18-fluorodeoxyglucose PET. MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995; 36: 1747-57.
24. Laubenbacher C, Kau RJ, Alexiou C et al. Kopf-Hals-Tumoren. In: PET in der Onkologie: Grundlagen und klinische Anwendungen. Ruhlmann J, Oehr P, Biersack H-J (Hrsg.). Berlin, Heidelberg: Springer 1998; 64-77.
25. Lenz M, Bongers H, Ozdoha C, Skalej M. The clinical value of computed tomography in the pretherapeutic T-staging of orofacial tumors. RöFo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 1989; 151: 138-44.
26. McGuirt WF, Williams III DW, Keyes JW Jr et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995; 105: 373-5.
27. McGuirt WF, Greven K, Keyes JW Jr et al. Laryngeal radionecrosis versus recurrent cancer: a clinical approach. Ann Otol Rhinol Laryngol 1998; 107: 293-6.
28. McGuirt WF, Greven K, Williams D 3rd et al. PET scanning in head and neck oncology: a review. Head Neck 1998; 20: 208-15.
29. Minn H, Joensuu H, Ahonen A, Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliterative activity of human cancer in vivo. Cancer 1988; 61: 1776-81.
30. Minn H, Lapela M, Klemi PJ et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 1997; 38: 1907-11.
31. Myers LL, Wax MK, Nabi H et al. Positron emission tomography in the evaluation of the N0 neck. Laryngoscope 1998; 108: 232-6.
32. Nitzsche EU, Hoegerle S, Juengling F et al. Nichtinvasive Dignitätsbestimmung von Pankreasläsionen mittels FDG-PET: Ist eine Beurteilung der FDG-Kinetik gegenüber der statischen Analyse von Vorteil? Nuklearmedizin 1998; 37: A11.
33. Rege S, Maass A, Chaiken L et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994; 73: 3047-58.
34. Reske SN, Bares R, Bull U et al. Clinical value of positron emission tomography (PET) in oncologic questions: results of an interdisciplinary consensus conference. Nuklearmedizin 1996; 35: 42-52.
35. Reske SN et al. Konsensus - Onko-PET. Nuklearmedizin 1997; 36: 45-6.
36. Scheidhauer K, Jungehülsing M, Pietrzyk U, Schicha H. FDG-PET zum Nachweis unbekannter Primärtumoren (CUP-Syndrom). Nuklearmedizin 1998; 37: A11.
37. Schipper JH, Schrader M, Arweiler D et al. Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor. HNO 1996; 44: 254-7.
38. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. Am J Roentgenol 1992; 156: 961-9.
39. Spitz MR. Epidemiology and risk factors for head and neck cancer. Sem Oncol 1994; 21: 281-8.
40. Steiner W. Early detection of cancer in the upper aerodigestive tract, Part I. HNO 1993; 41: 360-7.
41. Steinkamp HJ, Maurer J, Heim T et al. Magnetic resonance tomography and computerized tomography in tumor staging of mouth and oropharyngeal cancer. HNO 1993; 41: 519-25.
42. Thill R, Neuerburg J, Fabry U et al. Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma. Nuklearmedizin 1997; 36: 234-9.
43. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Medical progress: head and neck cancer. N Engl J Med 1993; 328: 184-94.